Mara H. Rendi

3.7k total citations · 1 hit paper
45 papers, 2.1k citations indexed

About

Mara H. Rendi is a scholar working on Pathology and Forensic Medicine, Oncology and Cancer Research. According to data from OpenAlex, Mara H. Rendi has authored 45 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 17 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Mara H. Rendi's work include Breast Lesions and Carcinomas (16 papers), Breast Cancer Treatment Studies (12 papers) and MRI in cancer diagnosis (7 papers). Mara H. Rendi is often cited by papers focused on Breast Lesions and Carcinomas (16 papers), Breast Cancer Treatment Studies (12 papers) and MRI in cancer diagnosis (7 papers). Mara H. Rendi collaborates with scholars based in United States, United Kingdom and Canada. Mara H. Rendi's co-authors include Rochelle L. Garcia, Kathy Agnew, Barbara M. Norquist, Elizabeth M. Swisher, Christopher C. Pennil, Tom Walsh, Ming K. Lee, Sheena Scroggins, Colin C. Pritchard and Mary‐Claire King and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Genetics.

In The Last Decade

Mara H. Rendi

43 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas

2013 712 citations Kathryn P. Pennington, Tom Walsh et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Mara H. Rendi

Since Specialization

Citations

This map shows the geographic impact of Mara H. Rendi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mara H. Rendi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mara H. Rendi more than expected).

Fields of papers citing papers by Mara H. Rendi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mara H. Rendi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mara H. Rendi. The network helps show where Mara H. Rendi may publish in the future.

Co-authorship network of co-authors of Mara H. Rendi

This figure shows the co-authorship network connecting the top 25 collaborators of Mara H. Rendi. A scholar is included among the top collaborators of Mara H. Rendi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mara H. Rendi. Mara H. Rendi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis 2021 ·npj Breast Cancer ·Jennifer Xiao, Habib Rahbar, Daniel S. Hippe, Mara H. Rendi, Elizabeth U. Parker, (unknown), (unknown), Kevin Cheung, Savannah C. Partridge	44
2	Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study 2019 ·Breast Cancer Research ·(unknown), Daniel S. Hippe, Habib Rahbar, Sana Parsian, Mara H. Rendi, Savannah C. Partridge	24
3	Diffusion‐weighted MRI characteristics associated with prognostic pathological factors and recurrence risk in invasive ER+/HER2– breast cancers 2017 ·Journal of Magnetic Resonance Imaging ·Nita Amornsiripanitch, (unknown), Habib Rahbar, Daniel S. Hippe, Vijayakrishna K. Gadi, Mara H. Rendi, Savannah C. Partridge	34
4	Surgical implications and variability in the use of the flat epithelial atypia diagnosis on breast biopsy specimens 2017 ·The Breast ·(unknown), Mara H. Rendi, Frederick A. Spencer, Kimberly H. Allison, Heidi D Nelson, Thomas R. Morgan, Donald L. Weaver, Joann G. Elmore	11
5	Epithelioid angiosarcoma arising in a uterine leiomyoma with associated elevated CA-125: A case report 2017 ·Gynecologic Oncology Reports ·Sarah Strickland, Mark Kilgore, (unknown), Mara H. Rendi	4
6	‘Non-classical’ HER2 FISH results in breast cancer: a multi-institutional study 2016 ·Modern Pathology ·(unknown), Florencia G. Jalikis, Gregor Krings, Rodney A. Schmidt, Yunn‐Yi Chen, Mara H. Rendi, Suzanne M. Dintzis, Kristin C. Jensen, Robert B. West, Richard K. Sibley, Megan L. Troxell, Kimberly H. Allison	68
7	Screening MRI in Women With a Personal History of Breast Cancer 2016 ·JNCI Journal of the National Cancer Institute ·Constance D. Lehman, Janie M. Lee, Wendy B. DeMartini, Daniel S. Hippe, Mara H. Rendi, (unknown), Peggy L. Porter, Julie R. Gralow, Savannah C. Partridge	104
8	Diffusion-weighted imaging reflects variable cellularity and stromal density present in breast fibroadenomas 2016 ·Clinical Imaging ·Sana Parsian, Nadia V. Giannakopoulos, Habib Rahbar, Mara H. Rendi, Xiaoyu Chai, Savannah C. Partridge	18
9	Region of interest identification and diagnostic agreement in breast pathology 2016 ·Modern Pathology ·(unknown), Ezgi Mercan, Donald L. Weaver, Tad T. Brunyé, Patricia A. Carney, Mara H. Rendi, Andrew H. Beck, Frederick A. Spencer, Linda G. Shapiro, Joann G. Elmore	15
10	NDER: A novel web application using annotated whole slide images for rapid improvements in human pattern recognition 2016 ·Journal of Pathology Informatics ·Nicholas P. Reder, (unknown), Suzanne M. Dintzis, Mara H. Rendi, Rochelle L. Garcia, Jonathan C. Henriksen, Mark Kilgore	5
11	Extracting a low-dimensional description of multiple gene expression datasets reveals a potential driver for tumor-associated stroma in ovarian cancer 2016 ·Genome Medicine ·Safiye Çelik, Benjamin A. Logsdon, Stephanie L. Battle, Charles W. Drescher, Mara H. Rendi, R. David Hawkins, Su‐In Lee	13
12	Reflex test reminders in required cancer synoptic templates decrease order entry error: An analysis of mismatch repair immunohistochemical orders to screen for Lynch syndrome 2016 ·Journal of Pathology Informatics ·Mark Kilgore, (unknown), Rodney A. Schmidt, Barbara M. Norquist, Elizabeth M. Swisher, Rochelle L. Garcia, Mara H. Rendi	5
13	Pleomorphic Lobular Carcinoma In Situ: Radiologic–Pathologic Features and Clinical Management 2015 ·Annals of Surgical Oncology ·Meghan R. Flanagan, Mara H. Rendi, Kristine E. Calhoun, Benjamin O. Anderson, Sara H. Javid	48
14	Adjuvant Endocrine Therapy in Patients with Ductal Carcinoma In Situ: A Population-Based Retrospective Analysis from 2005 to 2012 in the National Cancer Data Base 2015 ·Annals of Surgical Oncology ·Meghan R. Flanagan, Mara H. Rendi, Vijayakrishna K. Gadi, Kristine E. Calhoun, Kenneth W. Gow, Sara H. Javid	23
15	Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ? 2015 ·Clinical Imaging ·Habib Rahbar, Sana Parsian, Diana L. Lam, Brian N. Dontchos, Nicole K. Andeen, Mara H. Rendi, Constance D. Lehman, Savannah C. Partridge	11
16	Colonization of the upper genital tract by vaginal bacterial species in nonpregnant women 2014 ·American Journal of Obstetrics and Gynecology ·Caroline M. Mitchell, Anoria K. Haick, Evangelyn Nkwopara, Rochelle L. Garcia, Mara H. Rendi, Kathy Agnew, David N. Fredricks, David A. Eschenbach	275
17	Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas breakdown → 2013 ·Clinical Cancer Research ·Kathryn P. Pennington, Tom Walsh, Maria I. Harrell, Ming K. Lee, Christopher C. Pennil, Mara H. Rendi, Anne Thornton, Barbara M. Norquist, Silvia Casadei, Alex S. Nord, Kathy Agnew, Colin C. Pritchard, Sheena Scroggins, Rochelle L. Garcia, Mary‐Claire King, Elizabeth M. Swisher	712
18	Painful clitoromegaly caused by rare epithelioid hemangioma 2012 ·PubMed ·Heidi J. Gray, Mara H. Rendi, (unknown)	3
19	Lobular In-Situ Neoplasia on Breast Core Needle Biopsy: Imaging Indication and Pathologic Extent Can Identify Which Patients Require Excisional Biopsy 2011 ·Annals of Surgical Oncology ·Mara H. Rendi, Suzanne M. Dintzis, Constance D. Lehman, Kristine E. Calhoun, Kimberly H. Allison	94
20	A novel dicyanotriterpenoid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide production 2002 ·Bioorganic & Medicinal Chemistry Letters ·Tadashi Honda, Yukiko Honda, Frank G. Favaloro, Gordon W. Gribble, Nanjoo Suh, Andrew E. Place, Mara H. Rendi, Michael B. Sporn	129

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact